FDA Clearance Tracker · K142664
URight Hemoglobin A1c system, FORA A1c System
Last checked: Nov 20, 2026Latest source record: Jan 29, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Jan 29, 2016
Substantially Equivalent
Time to decision
498 days
Received Sep 18, 2014. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K142664
- Device name
- URight Hemoglobin A1c system, FORA A1c System
- Applicant
- Taidoc Technology Corporation
- Applicant location
- New Taipei City, TW
- Received
- Sep 18, 2014
- Decided
- Jan 29, 2016
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Assay, Glycosylated Hemoglobin (LCP)
- Device class
- Class II
- Regulation
- 21 CFR 864.7470
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LCP. The earliest in FDA's data is K780819, decided Nov 7, 1978.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K142664
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Taidoc Technology Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K221349 · Decided Nov 19, 2024 · 925 days after receipt
Device type: Prescription Use Blood Glucose Meter For Near-Patient Testing (PZI) · Laboratory Medicine & Pathology
K201037 · Decided Jun 16, 2022 · 787 days after receipt
Device type: System, Test, Blood Glucose, Over The Counter (NBW) · Laboratory Medicine & Pathology
K200946 · Decided Apr 5, 2022 · 727 days after receipt
Device type: Continuous Measurement Thermometer (FLL) · Hospital Medicine & Nursing
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.